But, remember, just because something claims to aid in weight loss, doesn't mean it actually does
Retatrutide Dosage Protocols from Clinical Trials Phase 2 clinical trials published in The New England Journal of Medicine in 2023 established the foundational retatrutide dosage framework [6]: Standard Retatrutide Dosing Schedule: 4 mg weekly Lower effective dose with moderate efficacy 8 mg weekly Mid-range dose with enhanced metabolic effects 12 mg weekly Maximum studied dose achieving 24.2% mean weight reduction The 12 mg dose demonstrated the most significant metabolic effects but also carried the highest incidence of gastrointestinal adverse events, with nausea reported in 60-80% of participants [7]
Sylvia Rosas, MD, MSCE, Joslin Diabetes Center, who concluded the symposium with an independent commentary of the FLOW trial findings
doi: 10.1146/annurev.nu.03.070183.001313
This means it didnt promote comedone formation in standard models
RNA isolation was conducted as mentioned above